CD34 and acute myeloid leukemia: Flow sorted CD34 positive primary RUNX1-mutated AML blasts co-cultured with HUVEC_AD52 cells were more sensitive to BTX-A51 (IC50 17nM) than venetoclax (IC50 82nM) (Fig. 5A).